Osteoporosis is an underdiagnosed disease. Patients with circumscribed risk factors should not be deprived of a bone density measurement. Although osteoporosis cannot be completely cured, its progression can be delayed with effective treatment. The current guideline defines treatment indication thresholds for the use of specific osteoporosis drugs (antiresorptives, osteoanabolics). In general, treatment should be tailored to the patient’s individual situation.
Autoren
- Mirjam Peter, M.Sc.
Publikation
- HAUSARZT PRAXIS
Related Topics
You May Also Like
- Sleep disorder
Sleep medicine in transition: new goals and a reassessment of old hypnotics
- Ginkgo biloba extract in the Alzheimer's mouse model
Effects on disease-associated microglia subpopulations
- "Patients W.A.I.T Indicator"
Access to medicines – how does Switzerland compare across Europe?
- Adherence in severe or poorly controlled asthma
Digital monitoring with potential for greater treatment adherence
- Crohn's disease and depression
Significant psychological stress for CD patients
- Epilepsy
Cannabidiol for refractory epilepsy syndromes
- Stomach cancer and Helicobacter pylori
A question of income?
- Prurigo nodularis and AD